Elsevier

Hepatology

Volume 22, Issue 3, September 1995, Pages 833-836
Hepatology

Other clinical study
Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet

https://doi.org/10.1016/0270-9139(95)90305-4Get rights and content

Abstract

The prevalence of hypertransaminasemia and the effect of gluten-free diet (GFD) were evaluated in 158 consecutive adult celiac patients, 127 women and 31 men, aged 18 to 68 years (mean, 32). At diagnosis, 67 patients (42%) had raised aspartate and/or alanine transaminase levels (AST and ALT; mean, 47 IU/L, range, 30 to 190; and 61 IU/L, range, 25 to 470, respectively), whereas 91 patients had normal liver function tests (LFT). Patients with and without hypertransaminasemia were comparable for epidemiological data, body mass index (18.5 vs. 19.6), and severity of intestinal histological involvement. All patients were given a strict GFD and were followed for 1 to 10 years (median, 4). At 1 year, a highly significant improvement in intestinal histology was observed in both groups (P < .0001). In the 67 patients with raised transaminase levels body mass index (BMI) also increased significantly (from 18.5 to 21.0, P < .001), and transaminase levels normalized in 60 (95%). In the other seven cases liver biopsy showed fatty infiltration in two and chronic active hepatitis (CAH) in the other five, related to chronic infection with hepatitis B virus in three and hepatitis C virus in one, and to autoimmune type in the fifth. We conclude that in adult celiac patients elevated serum transaminases are a frequent finding and normalize in most cases after GFD. When they persist, liver biopsy is mandatory to further investigate hepatic involvement, which in our series was mainly attributable to CAH.

References (23)

  • B Hagander et al.

    Hepatic injury in celiac disease

    Lancet

    (1977)
  • SN Lichtman et al.

    Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth

    Gastroenterology

    (1990)
  • JP Capron et al.

    Stéatose hepatique massive révélatrice d'une maladie coeliaque de l'adulte

  • DA Lynch et al.

    Acute fatty liver complicating coeliac disease

    Eur J Gastroenterol Hepatol

    (1994)
  • JE Hay et al.

    Primary sclerosing cholangitis and celiac disease: a novel association

    Ann Intern Med

    (1988)
  • F Brazier et al.

    Primary sclerosing cholangitis and coeliac disease: beneficial effect of gluten-free diet on the liver

    Eur J Gastroenterol Hepatol

    (1994)
  • R Olsson et al.

    On the occurrence of primary biliary cirrhosis and intestinal villous atrophy

    Scand J Gastroenterol

    (1982)
  • G Maggiore et al.

    Celiac disease presenting as chronic hepatitis in a girl

    J Pediatr Gastroenterol Nutr

    (1986)
  • S Leonardi et al.

    Hypertransaminasemia as the first symptom in infant celiac disease

    J Pediatr Gastroenterol Nutr

    (1990)
  • P Vairo et al.

    Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy

    J Pediatr

    (1993)
  • BB Scott et al.

    Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis

    Gut

    (1976)
  • Cited by (217)

    • The tight junction and the epithelial barrier in coeliac disease

      2021, International Review of Cell and Molecular Biology
    • ESPEN practical guideline: Clinical nutrition in liver disease

      2020, Clinical Nutrition
      Citation Excerpt :

      According to a systematic analysis [153] the hazard ratio for NAFL/NASH is 2.8 (95% CI 2.0–3.8) in celiac disease patients with and even higher in the subgroup of children (HR 4.6; 95% CI 2.3-0.1). There are several reports on improvement or even normalization of transaminases with response rates up to 75%–100% upon institution of a gluten free diet [154–158]. A case series from Finland reported on four patients with serious liver disease referred to the transplantation center in whom celiac disease was diagnosed during the evaluation.

    • The Liver and Celiac Disease

      2019, Clinics in Liver Disease
      Citation Excerpt :

      Most patients with celiac hepatitis have no symptoms or signs of liver disease.6,7,15 Thus, the presence of palmar erythema, jaundice, ascites, splenomegaly, encephalopathy, coagulopathy, or portal hypertension suggests advanced liver disease or the coexistence with other chronic liver disease.3,6 Mild to moderate (less than 5 times the upper limit of normal) levels of aspartate aminotransferase and/or alanine aminotransferase are typical.6,7,12,16

    View all citing articles on Scopus

    Supported by Associazione Italiana Celiachia (Sezione Lombardia) and Associazione Amici Gastroenterologia Granelli.

    View full text